Cancer after Total Joint Arthroplasty: A Meta-analysis
Open Access
- 1 August 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (8), 1532-1537
- https://doi.org/10.1158/1055-9965.epi-06-0127
Abstract
It has been hypothesized that breast cancer risk is influenced by prenatal hormone levels. Diethylstilbestrol (DES), a synthetic estrogen, was widely used by pregnant women in the 1950s and 1960s. Women who took the drug have an increased risk of breast cancer, but whether risk is also increased in the daughters who were exposed in utero is less clear. We assessed the relation of prenatal DES exposure to risk of breast cancer in a cohort of DES-exposed and unexposed women followed since the 1970s by mailed questionnaires. Eighty percent of both exposed and unexposed women completed the most recent questionnaire. Self-reports of breast cancer were confirmed by pathology reports. Cox proportional hazards regression was used to compute incidence rate ratios (IRR) for prenatal DES exposure relative to no exposure. During follow-up, 102 incident cases of invasive breast cancer occurred, with 76 among DES-exposed women (98,591 person-years) and 26 among unexposed women (35,046 person-years). The overall age-adjusted IRR was 1.40 [95% confidence interval (95% CI), 0.89-2.22]. For breast cancer occurring at ages ≥40 years, the IRR was 1.91 (95% CI, 1.09-3.33) and for cancers occurring at ages ≥50 years, it was 3.00 (95% CI, 1.01-8.98). Control for calendar year, parity, age at first birth, and other factors did not alter the results. These results, from the first prospective study on the subject, suggest that women with prenatal exposure to DES have an increased risk of breast cancer after age 40 years. The findings support the hypothesis that prenatal hormone levels influence breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2006;15(8):1509–14)This publication has 47 references indexed in Scilit:
- Measuring inconsistency in meta-analysesBMJ, 2003
- IS HEXAVALENT CHROMIUM CARCINOGENIC VIA INGESTION? A WEIGHT-OF-EVIDENCE REVIEWJournal of Toxicology and Environmental Health, Part A, 2002
- Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies — a report of an IARC Monographs Programme MeetingEuropean Journal of Cancer, 2000
- Cancer risk among patients with finger and hand joint and temporo-mandibular joint prostheses in DenmarkInternational Journal of Cancer, 1999
- Cancer incidence after total knee arthroplasty: A nationwide Finnish cohort from 1980 to 1996 involving 9,444 patientsActa Orthopaedica, 1999
- Toxicity and Carcinogenicity of Cr(VI) in Animal Models and HumansCritical Reviews in Toxicology, 1997
- Neoplastic lymphoproliferation in autoimmune disease: An updated reviewClinical Immunology and Immunopathology, 1992
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritisJournal of Chronic Diseases, 1978